NPPA fixes retail price of 29 formulations, details

Written by Dr. Divya Colin Published On 2023-10-30T16:30:59+05:30 | Updated On 30 Oct 2023 5:17 PM IST

NPPA fixes retail price of 29 formulations, details

New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India, has fixed the retail price of 29 formulations including those used to treat high blood pressure, type 2 diabetes, certain types of inflammation associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, muscle pain, bone pain, and joint pain, also dietary supplements and antacids.

This came in line with the decision of the 117th authority meeting dated 13.10.2023.

This includes Akums Drugs/Mankind Pharma's Cilnidipine and Telmisartan Tablets, Synokem Pharmaceuticals/ Cipla's Montelukast and Fexofenadine Hydrochloride Suspension, Exemed Pharmaceuticals /Eris Lifesciences's Linagliptin plus Metformin Hydrochloride (ER) Tablet, Akums Drugs / Zuventus Healthcare's Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet, Alkem Health Science's Linagliptin plus Metformin Hydrochloride (ER) Tablet and others.

This came in the exercise of the powers conferred by paragraphs 5, 11, and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May 2013 and S. O. 5249(E) dated 11th November 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (NPPA), has fixed, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer and marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;

Sl. No.	Name of the Formulation / Brand Name	Strength	Unit	Manufacturer & Marketing Company	Retail Price (Rs.)
(1)	(2)	(3)	(4)	(5)	(6)
1	Paracetamol, Phenylephrine Hydrochloride, Caffeine & Diphenhydramine ne Hydrochloride Tablets	Each uncoated tablet contains: Paracetamol IP 500mg Phenylephrine Hydrochloride IP 5mg Caffeine (Anhydrous) IP 30mg Diphenhydramine Hydrochloride IP 25mg	1 Tablet	M/s Prosperity Drugs Pvt. Ltd. / M/s Torrent Pharmaceuticals Limited	3.85
2	Cilnidipine and Telmisartan Tablets	Each film-coated tablet contains: Cilnidipine IP 20mg Telmisartan IP 40mg	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Mankind Pharma Ltd.	14.15
3	Ibuprofen Solution for Infusion 400mg/100ml	Each 100ml contains: Ibuprofen IP 400mg Water for injection IP q. s.	1 ML	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Neon Laboratories Limited	2.63
4	Phenylephrine Hydrochloride and Chlorpheniramine Maleate Drops IP	Each ml contains: Phenylephrine Hydrochloride IP 5mg Chlorpheniramine Maleate IP 2mg	1 ML	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Apex Laboratories Pvt. Ltd.	4.28
5	Ofloxacin and Dexamethasone Eye / Ear Drops	Each ml contains: Ofloxacin IP 0.3% w/v Dexamethasone Sodium Phosphate IP eq. to	1 ML	M/s Axa Parenterals Ltd. / M/s Intas Pharmaceuticals	6.00

Sl. No.	Name of the Formulation / Brand Name	Strength	Unit	Manufacturer & Marketing Company	Retail Price (Rs.)
(1)	(2)	(3)	(4)	(5)	(6)
		Dexamethasone Phosphate 0.1% w/v Benzalkonium Chloride Solution IP 0.02% (As preservative)		Ltd.
6	Montelukast and Fexofenadine Hydrochloride suspension	Each 5ml contains: Montelukast Sodium IP eq. to Montelukast 4mg Fexofenadine Hydrochloride IP 60mg	1 ML	M/s Synokem Pharmaceuticals Ltd. / M/s Cipla Ltd.	1.79
7	Linagliptin + Metformin Hydrochloride (ER) Tablet	Each film-coated bilayer tablet contains: Linagliptin 2.5mg Metformin Hydrochloride (as Extended release) IP 1000mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s ERIS Lifesciences Limited	9.60
8	Calcium, Magnesium, Vitamin D3 & Zinc Tablets	Each uncoated tablet contains: Calcium Citrate USP 1000mg Vitamin D3 IP 200IU Magnesium Hydroxide IP eq. to elemental magnesium 100mg Zinc Sulphate Monohydrate IP eq. to elemental Zinc 4mg	1 Tablet	M/s Hanuchem Laboratories / M/s Mankind Pharma Ltd.	9.64
9	Mefenamic Acid + Paracetamol Suspension	Each 5ml contains: Mefenamic Acid IP 50mg Paracetamol IP 125mg	1 ML	M/s Innova Captab Limited / M/s Macleods Pharmaceuticals Limited	0.68
10	Mefenamic Acid+ Paracetamol Suspension	Each 5ml contains: Mefenamic Acid IP 100mg Paracetamol IP 250mg	1 ML	M/s Innova Captab Limited / M/s Macleods Pharmaceuticals Limited	0.82
11	Calcium, Vitamin D3 & Vitamin B12 Tablets	Each film-coated tablet contains: Calcium Carbonate 1250mg from an organic source (Oyster shell) eq. to Elemental Calcium 500mg Vitamin D3 IP 500 IU Vitamin B12 IP 15mcg	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Cipla Ltd.	8.58
12	Atorvastatin, Clopidogrel and Aspirin Capsules	Each hard gelatin capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 40mg (As two film-coated tablets) Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg, Aspirin IP 75mg (As a Gastro-resistant tablet)	1 Capsule	M/s Safetab Life Science / M/s Lupin Limited	13.22
13	Ferrous	Each film-coated tablet	1 Tablet	Pure and Cure	10.37

Sl. No.	Name of the Formulation / Brand Name	Strength	Unit	Manufacturer & Marketing Company	Retail Price (Rs.)
(1)	(2)	(3)	(4)	(5)	(6)
	Ascorbate, Folic Acid, Zinc & Cyanocobalamin Tablets	contains: Ferrous Ascorbate IP eq. to Elemental Iron 100mg Folic Acid IP 1.5mg Zinc Sulphate Monohydrate IP eq. to Elemental Zinc 22.5mg Cyanocobalamin IP 15mcg		Healthcare Pvt. Ltd. / M/s Cipla Ltd.
14	Methylcobalami n, Nicotinamide, Pyridoxine Hydrochloride & D-panthenol Injection	Each 2ml contains: Methylcobalamin IP 1000mcg, Nicotinamide 100mg, Pyridoxine Hydrochloride IP 100mg, D-panthenol IP 50mg Benzyl Alcohol IP 2% v/v (As preservative)	Per vial of 2ml	M/s Fast Pharma Pvt. Ltd. / M/s German Remedies Pharmaceuticals Pvt. Ltd.	66.50
15	Atorvastatin & Ezetimibe Tablets	Each film coated tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 40mg Ezetimibe IP 10mg	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Emcure Pharmaceuticals Limited	32.61
16	Glycopyrronium + Formoterol Fumarate + Budesonide powder for Inhalation	Each capsule contains: Formoterol Fumarate Dihydrate IP eq. to Formoterol Fumarate 12mcg Glycopyrrolate IP eq. to Glycopyrronium 25mcg Budesonide IP 400mcg	1 Capsule	M/s Penta Kraft / M/s Mankind Pharma Ltd.	12.98
17	Omeprazole & Domperidone Capsules IP	Each hard gelatin capsule contains: Omeprazole IP 20mg (As enteric coated pellets) Domperidone IP 10mg (As coated pellets)	1 Capsule	M/s Prochem Pharmaceuticals Pvt. Ltd. / M/s German Remedies Pharmaceuticals Pvt. Ltd.	6.14
18	Nimesulide& Paracetamol tablet	Each uncoated tablet contains: Nimesulide BP 100mg Paracetamol IP 325mg	1 Tablet	M/s Lucent Biotech Limited / M/s Torrent Pharmaceuticals Ltd.	3.91
19	Sitagliptin Phosphate & Metformin Hydrochloride Tablet	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP 64.25mg eq. to Sitagliptin 50mg Metformin Hydrochloride IP 500mg	1 Tablet	M/s Windlas Biotech Limited	9.16
20	Sitagliptin Phosphate & Metformin Hydrochloride Tablet	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP 64.25mg eq. to Sitagliptin 50mg	1 Tablet	M/s Windlas Biotech Limited	10.37

Sl. No.	Name of the Formulation / Brand Name	Strength	Unit	Manufacturer & Marketing Company	Retail Price (Rs.)
(1)	(2)	(3)	(4)	(5)	(6)
		Metformin Hydrochloride IP 1000mg
21	Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet	Each film coated Bilayered Tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 1000mg (Sustained Release Form)	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Zuventus Healthcare Limited	17.16
22	Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet	Each film coated Bilayered Tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 500mg (Sustained Release Form)	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Zuventus Healthcare Limited	16.09
23	Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet	Each film coated Bilayered Tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 1000mg (Sustained Release Form)	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Primus Remedies Pvt. Ltd.	17.16
24	Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet	Each film coated Bilayered Tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 500mg (Sustained Release Form)	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Primus Remedies Pvt. Ltd.	16.09
25	Linagliptin + Metformin Hydrochloride (ER) Tablet	Each film bilayer coated tablet contains: Linagliptin 5mg Metformin Hydrochloride (as Extended release) IP 1000mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s ERIS Lifesciences Limited	14.37
26	Linagliptin + Metformin Hydrochloride (ER) Tablet	Each film coated Bilayered tablet contains: Linagliptin 5mg Metformin IP 1000mg Hydrochloride (as Extended	1 Tablet	M/s Alkem Health Science (A unit of Alkem Laboratories Ltd.) / M/s Alkem	14.37

Sl. No.	Name of the Formulation / Brand Name	Strength	Unit	Manufacturer & Marketing Company	Retail Price (Rs.)
(1)	(2)	(3)	(4)	(5)	(6)
		release)		Laboratories Ltd.
27	Linagliptin + Metformin Hydrochloride (ER) Tablet	Each film coated Bilayered tablet contains: Linagliptin 5mg Metformin Hydrochloride IP 500mg (as Extended release)	1 Tablet	M/s Alkem Health Science (A unit of Alkem Laboratories Ltd.) / M/s Alkem Laboratories Ltd.	12.92
28	Dapagliflozin, Sitagliptin and Metformin Hydrochloride Tablets	Each film coated tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 5mg Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Eris Lifesciences Limited	14.62
29	Dapagliflozin, Sitagliptin and Metformin Hydrochloride Tablets	Each film coated tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 5mg Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 500mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Eris Lifesciences Limited	13.55

The notification further added;

(a) The manufacturer of the above-mentioned formulations i.e., “new drug” under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.

(b) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above-said table.

(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from the date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to the State Drug Controller and dealers.

(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display the price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.

(e) The above-mentioned retail price is applicable only to the individual manufacturer/marketer as mentioned above i.e. who has applied for the same by submitting Form-I for price fixation/revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.

(f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.

(g) Consequent to the fixation of the retail price of such formulation as specified in column (2) of the above table with the strength and name of Manufacturer and marketing Companies specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer & Marketing Companies as specified in corresponding entries in Columns (2), (3) and (5) thereof, if any, issued prior to this notification, stand(s) superseded.

To view the notice, click the link below:

https://medicaldialogues.in/pdf_upload/retail-engl-224064.pdf

Also Read: NPPA fixes retail prices of 44 formulations

npparetail priceprice fixationdrug priceciplaalkemakums drugNational Pharmaceutical Pricing Authority

Dr. Divya Colin

Doctor of Pharmacy

Dr. Divya Colin, a Doctor of Pharmacy Graduate with extensive experience in clinical and hospital settings and confidently equipped with diagnostic and therapeutic skills. She also has spread out exposure to Oncology Departments in Mysore Medical College and Research Institute as Oncology Pharmacist. Currently she is building a career in clinical research and clinical data management. She has been a part of Medical Dialogue since January 2022.